#clinical trial — Saturday, July 25, 2026 (1 items)
| 0 | 💬 0 |
Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial.
(nature.com)
|
Nature Communications 2026-07-25 | #immune-thrombocytopenia #clinical trial #immunosuppression #autoimmunity |